Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas

Numerous studies have demonstrated the clinical activity of temozolomide, a second-generation alkylating agent, against malignant brain tumors, however, its activity has not been reported in an Asian population. This study analyzed the efficacy and toxicity of temozolomide in 25 adult patients with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang, Seung-Ho, Kim, Moon-Kyu, Lee, Tae-Kyu, Lee, Kwan-Sung, Jeun, Sin-Soo, Park, Chun-Kun, Kang, Joon-Ki, Kim, Moon-Chan, Hong, Yong-Kil
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Academy of Medical Sciences 2006
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2729901/
https://ncbi.nlm.nih.gov/pubmed/16891823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2006.21.4.739
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares